학술논문
Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks.
Document Type
Article
Author
Source
Subject
*PATIENT satisfaction
*MULTIPLE sclerosis treatment
*INTERFERON beta-1a
*MULTIPLE sclerosis
*SUBCUTANEOUS infusions
*PATIENTS
*
*
*
*
*
Language
ISSN
1177-889X
Abstract
The article presents a study which analyzes the treatment satisfaction of patients with multiple sclerosis who switch from interferon (IFN) beta therapy to subcutaneous (SC) peginterferon beta-1a therapy. It states that the Treatment Satisfaction Questionnaire for Medication (TSQM) was used to measure treatment satisfaction. Particular focus is given to the significance of switching to SC peginterferon beta-1a therapy.